Insider · CIK 0002014509
Constantine Chinoporos
Files at GERN (GERON CORP), APLT (Applied Therapeutics, Inc.). First filing Feb 7, 2025, latest Mar 6, 2025.
Constantine Chinoporos files SEC Form 4 as officer and director at APLT (Applied Therapeutics, Inc.), and also at GERN (GERON CORP). Since Feb 7, 2025, Constantine Chinoporos has reported 0 open-market buys worth $0 and 2 open-market sells worth $17k, the latest filed on Mar 6, 2025.
A track record needs three past buys with six months of prices behind them; Constantine Chinoporos has 0, so none is measured yet.
The newest scored trade: sold $197 of APLT on Mar 4, 2025, filed Mar 6, 2025, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Applied Therapeutics, Inc. | $197 447 shares | -0% | - | |
| 30Weak | Applied Therapeutics, Inc. | $17k 28,117 shares | -9% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | GERN GERON CORP | AGrant or award Stock Option (Right to Buy)derivative | +270,000 | $0.00 | $0 | 270,000 | Mar 26, 2026 |
| Dec 19, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +437,500 | $0.00 | $0 | 1,057,111 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | DDisposition to issuer Common Stock | -1,000,000 | - | - | 57,111 | Feb 3, 2026 |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | UTender of shares Common Stock | -57,111 | - | - | 0 | Feb 3, 2026 |
| Mar 24, 2025 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +350,000 | $0.00 | $0 | 621,436 | Mar 26, 2025 |
| Mar 4, 2025 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -447 | $0.44 | $197 | 271,436 | Mar 6, 2025 |
| Feb 6, 2025 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -28,117 | $0.61 | $17k | 271,883 | Feb 7, 2025 |
Questions about Constantine Chinoporos
Answered from the filings on this page, as of the latest one.
Is Constantine Chinoporos buying or selling?
Not in the last 12 months. Constantine Chinoporos's latest open-market trade on SEC Form 4 was sold $197 of APLT on Mar 4, 2025.
How did Constantine Chinoporos's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Constantine Chinoporos has 0.
Where does Constantine Chinoporos file Form 4?
Constantine Chinoporos has filed Form 4 at APLT (Applied Therapeutics, Inc.) as See Remarks; GERN (GERON CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.